Article

Risk Factors for Mumps at a University with a Large Mumps Outbreak

Epidemic Intelligence Service, Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Public Health Reports (Impact Factor: 1.55). 05/2009; 124(3):419-26.
Source: PubMed

ABSTRACT

Routine measles-mumps-rubella (MMR) vaccine use has greatly decreased the incidence of mumps in the U.S. However, a resurgence of mumps occurred in 2006. We investigated the large outbreak at a university and assessed risk factors for disease.
We described the outbreak and conducted a case-control study. We interviewed case students (identified from student health service and health department records) and control students (selected from a randomly ordered administrative list) and assessed their vaccination status. We compared case students with > or = 2 MMR doses and control students with > or = 2 MMR doses in univariate and multivariate analyses.
The mean age of the 174 case students was 20.9 years; 65% were women. Ninety-seven case students and 147 control students were enrolled in the study. Two-dose MMR coverage was 99% among case and control students with complete records. Only 33% of case students reported exposure to someone with mumps. Case students were more likely than control students to be aged 18 to 19 years (vs. aged 22 years, adjusted odds ratio [AOR] = 5.55; 95% confidence interval [CI] 2.09, 14.74), to report exposure to mumps (AOR=2.31, 95% CI 1.13, 4.73), and to have worked/volunteered on campus (AOR=2.91, 95% CI 1.33, 6.33). Also, women in dormitories had increased odds of mumps compared with men in dormitories.
High two-dose MMR coverage was not sufficient to prevent the outbreak. Further study is needed to better understand the effects of dormitory residency and gender on mumps transmission. Clinicians should be vigilant for mumps in young adults presenting with parotitis regardless of immunization history.

Download full-text

Full-text

Available from: Gustavo H Dayan, Dec 31, 2013
  • Source
    • "Studies have shown, however, that even high two-dose levels of MMR coverage among university students may not be sufficient to prevent a mumps outbreak, as vaccine-induced protection may wane [9] [10], raising questions about the efficacy of the vaccine [11]. Evidence on waning immunity is required to assess whether a third dose of MMR vaccine, or possibly the use of a different vaccine, is required [12] "
    [Show abstract] [Hide abstract]
    ABSTRACT: Evidence suggests that primary and secondary vaccine failure have contributed to recent university-based mumps outbreaks. We describe the epidemiology and public health management of two such outbreaks that occurred simultaneously in two areas of the North West of England, affecting four universities, using data from routine surveillance, serology testing, and telephone interviews and electronic questionnaires. Vaccination status was obtained from GP records. Cases were predominantly first year students living in university halls of residence. Public health response involved active surveillance, isolation advice and targeted vaccination clinics. Many students lack natural immunity and mumps vaccination. Factors hindering the public health response include delayed notifications, inability to readily define the 'at risk' population, low vaccine uptake, and lack of an evidence-based, cost effective strategy.
    Full-text · Article · Mar 2011 · Vaccine
  • [Show abstract] [Hide abstract]
    ABSTRACT: Eine Xerostomie ist am häufigsten Folge einer medikamentösen Therapie insbesondere bei Medikamenten mit anticholinerger Wirkkomponente. Ebenso kann es nach Bestrahlung der Mund- und Rachenschleimhaut sowie des Halses und bei rheumatischen Erkrankungen (insbesondere beim Sjögren- Syndrom) zu Mundtrockenheit kommen. Auch bei einer Hepatitis C-Infektion kommt es häufig zu einem Sjögren-ähnlichen Krankheitsbild. Diese und weitere Ursachen einer Xerostomie wurden in einem Review von Napenas et al. (1) nochmals zusammengefasst.
    No preview · Article · Jan 2009
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Since December 2009, mumps incidence has increased in the Netherlands. As of 20 April 2010, 172 cases have been notified on the basis of laboratory confirmation or linkage to a laboratory-confirmed case. Of these, 112 were students, the majority of whom had been vaccinated (81%). Although outbreaks in vaccinated populations have been described before, risk factors for exposure and susceptibility, and dose-dependent vaccine effectiveness in a student population of this nature are relatively unknown.
    Full-text · Article · Apr 2010 · Eurosurveillance: bulletin europeen sur les maladies transmissibles = European communicable disease bulletin
Show more